| # | Drug | Count |
|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 3 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 2 |
| 2 | AMLODIPINE BESYLATE | 1 |
| 3 | BUPROPION HYDROCHLORIDE | 1 |
| 4 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 |
| 5 | DULAGLUTIDE | 1 |
| 6 | EMPAGLIFLOZIN | 1 |
| 7 | EVEROLIMUS | 1 |
| 8 | LITHIUM | 1 |
| 9 | LITHIUM BROMATUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 3 | 0.0005 |
| 1 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 2 | CILTACABTAGENE AUTOLEUCEL | 2 | 0.0003 |
| 3 | LITHIUM | 1 | 0.0000 |
| 4 | OCTREOTIDE ACETATE | 1 | 0.0000 |
| 5 | PANCRELIPASE | 1 | 0.0000 |
| 6 | EVEROLIMUS | 1 | 0.0000 |
| 7 | EMPAGLIFLOZIN | 1 | 0.0000 |
| 8 | DULAGLUTIDE | 1 | 0.0000 |
| 9 | BUPROPION HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 2 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 1 | 0.0000 |